The neuroprotective role of melatonin in neurological disorders

被引：168

作者：

Alghamdi, B. S. ^{[1
,2
]}

机构：

[1] King Abdulaziz Univ, Fac Med, Dept Physiol, Jeddah, Saudi Arabia

[2] King Abdulaziz Univ, Fac Med, Neurosci Unit, Jeddah, Saudi Arabia

来源：

JOURNAL OF NEUROSCIENCE RESEARCH | 2018年 / 96卷 / 07期

关键词：

melatonin; ischemia; alzheimer; parkinson; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; FAMILIAL ALZHEIMERS-DISEASE; OXIDATIVE STRESS HYPOTHESIS; MAMMALIAN PINEAL-GLAND; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID;

D O I：

10.1002/jnr.24220

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Melatonin is a neurohormone secreted from the pineal gland and has a wide-ranging regulatory and neuroprotective role. It has been reported that melatonin level is disturbed in some neurological conditions such as stroke, Alzheimer's disease, and Parkinson's disease, which indicates its involvement in the pathophysiology of these diseases. Its properties qualify it to be a promising potential therapeutic neuroprotective agent, with no side effects, for some neurological disorders. This review discusses and localizes the effect of melatonin in the pathophysiology of some diseases.

引用

页码：1136 / 1149

页数：14

共 200 条

[81] Alterations in the time course of expression of the Nox family in the brain in a rat experimental cerebral ischemia and reperfusion model: effects of melatonin
Li, Haiying
Wang, Yang
Feng, Dongxia
Liu, Yin
Xu, Min
Gao, Anju
Tian, Fengxuan
Zhang, Li
Cui, Yonghua
Wang, Zhong
Chen, Gang
[J]. JOURNAL OF PINEAL RESEARCH, 2014, 57 (01) : 110 - 119
[82] Melatonin attenuates arsenite-induced apoptosis in rat brain:: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of α-synuclein
Lin, Anya M. Y.
Fang, S. F.
Chao, P. L.
Yang, C. H.
[J]. JOURNAL OF PINEAL RESEARCH, 2007, 43 (02) : 163 - 171
[83] Ischemic cell death in brain neurons
Lipton, P
[J]. PHYSIOLOGICAL REVIEWS, 1999, 79 (04) : 1431 - 1568
[84] Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-ε4/4 genotype
Liu, RY
Zhou, JN
van Heerikhuize, J
Hofman, MA
Swaab, DF
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) : 323 - 327
[85] Cultured rat cortical astrocytes synthesize melatonin: absence of a diurnal rhythm
Liu, Ya-Jing
Zhuang, Jun
Zhu, Hong-Yan
Shen, Yu-Xian
Tan, Zhong-Lin
Zhou, Jiang-Ning
[J]. JOURNAL OF PINEAL RESEARCH, 2007, 43 (03) : 232 - 238
[86] Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations
Lleó, A
Berezovska, O
Growdon, JH
Hyman, BT
[J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (02) : 146 - 156
[87] Decreased Plasma Aβ in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction
Loeffler, Tina
Flunkert, Stefanie
Temmel, Magdalena
Hutter-Paier, Birgit
[J]. FRONTIERS IN NEUROSCIENCE, 2016, 10
[88] Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique
Longatti, Pierluigi
Perin, Alessandro
Rizzo, Vittoria
Comai, Stefano
Giusti, Pietro
Costa, Carlo Virgilio Luigi
[J]. JOURNAL OF PINEAL RESEARCH, 2007, 42 (02) : 113 - 118
[89] BETA-AMYLOID NEUROTOXICITY REQUIRES FIBRIL FORMATION AND IS INHIBITED BY CONGO RED
LORENZO, A
YANKNER, BA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) : 12243 - 12247
[90] Luboshitzky R, 2002, NEUROENDOCRINOL LETT, V23, P213

← 4 5 6 7 8 9 10 11 12 13 →